
Use of cutting-edge weight-loss drugs like Ozempic and Zepbound has increased dramatically among people with type 1 diabetes, raising safety concerns among experts, a new study says. Both adults and children with type 1 diabetes are taking the drugs more often to manage obesity, researchers reported in the journal Diabetes, Obesity and Metabolism. The problem… read on > read on >